NEW YORK (

TheStreet

) --

Quest Diagnostics

(NYSE:

DGX

) hit a new 52-week high Wednesday as it is currently trading at $61.34, above its previous 52-week high of $61.21 with 1.5 million shares traded as of 1:35 p.m. ET. Average volume has been 1.1 million shares over the past 30 days.

Quest has a market cap of $8.91 billion and is part of the

health care

sector and

health services

industry. Shares are up 4.6% year to date as of the close of trading on Tuesday.

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company has a P/E ratio of 20.8, equal to the average health services industry P/E ratio and above the S&P 500 P/E ratio of 17.7.

  • Sign up for TheStreet's FREE Dividend and Income Investor Newsletter

TheStreet Ratings rates Quest as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, expanding profit margins, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full

Quest Ratings Report

.

See all

52-week high stocks

or get investment ideas from our

investment research center

.

null